Sino Biopharmaceutical Statistics
Total Valuation
SBMFF has a market cap or net worth of 20.44 billion. The enterprise value is 21.08 billion.
| Market Cap | 20.44B |
| Enterprise Value | 21.08B |
Important Dates
The last earnings date was Monday, August 25, 2025.
| Earnings Date | Aug 25, 2025 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
| Current Share Class | 17.88B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.10% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.81B |
Valuation Ratios
The trailing PE ratio is 37.82 and the forward PE ratio is 32.98.
| PE Ratio | 37.82 |
| Forward PE | 32.98 |
| PS Ratio | 4.79 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 4.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 39.00 |
| EV / Sales | 4.90 |
| EV / EBITDA | 21.82 |
| EV / EBIT | 26.23 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.36 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 1.73 |
| Debt / FCF | n/a |
| Interest Coverage | 21.69 |
Financial Efficiency
Return on equity (ROE) is 15.40% and return on invested capital (ROIC) is 6.55%.
| Return on Equity (ROE) | 15.40% |
| Return on Assets (ROA) | 5.07% |
| Return on Invested Capital (ROIC) | 6.55% |
| Return on Capital Employed (ROCE) | 11.47% |
| Revenue Per Employee | 185,063 |
| Profits Per Employee | 23,438 |
| Employee Count | 24,379 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.83 |
Taxes
In the past 12 months, SBMFF has paid 120.07 million in taxes.
| Income Tax | 120.07M |
| Effective Tax Rate | 11.27% |
Stock Price Statistics
The stock price has increased by +159.27% in the last 52 weeks. The beta is 0.64, so SBMFF's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +159.27% |
| 50-Day Moving Average | 0.58 |
| 200-Day Moving Average | 0.53 |
| Relative Strength Index (RSI) | 83.56 |
| Average Volume (20 Days) | 4,102 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SBMFF had revenue of 4.27 billion and earned 540.39 million in profits. Earnings per share was 0.03.
| Revenue | 4.27B |
| Gross Profit | 3.49B |
| Operating Income | 801.24M |
| Pretax Income | 1.07B |
| Net Income | 540.39M |
| EBITDA | 962.63M |
| EBIT | 801.24M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 2.77 billion in cash and 1.67 billion in debt, giving a net cash position of 1.10 billion.
| Cash & Cash Equivalents | 2.77B |
| Total Debt | 1.67B |
| Net Cash | 1.10B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.39B |
| Book Value Per Share | 0.26 |
| Working Capital | 1.25B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 81.77%, with operating and profit margins of 18.78% and 12.67%.
| Gross Margin | 81.77% |
| Operating Margin | 18.78% |
| Pretax Margin | 24.96% |
| Profit Margin | 12.67% |
| EBITDA Margin | 22.56% |
| EBIT Margin | 18.78% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 1.16%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 1.16% |
| Dividend Growth (YoY) | 49.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 2.10% |
| Shareholder Yield | 3.26% |
| Earnings Yield | 2.64% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |